Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients

Journal of Hepatology

Volumn 50, Issue 5, 2009, Pages 980-989

  Zhang, Jing Ping ^a   Yan, Jing ^a   Xu, Jing ^a   Pang, Xiong Hao ^b   Chen, Min Shan ^b   Li, Li ^a   Wu, Changyou ^a   Li, Sheng Ping ^b   Zheng, Limin ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Angiogenesis; Hepatocellular carcinoma; Inflammation; Prognosis; Th17 cells

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CELL DENSITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HAZARD RATIO; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; TUMOR BLOOD FLOW;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL COUNT; FEMALE; HUMANS; INTERLEUKIN-17; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 64549108462     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.12.033     Document Type: Article

References (39)

1. Schwartz M., Roayaie S., and Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Prac Oncol 4 (2007) 424-432
2. Poon R.T., Ng I.O., Lau C., Yu W.C., Yang Z.F., Fan S.T., et al. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 20 (2002) 1775-1785
3. Semela D., and Dufour J.F. Angiogenesis and hepatocellular carcinoma. J Hepatol 41 (2004) 864-880
4. Mueller M.M., and Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4 (2004) 839-849
5. Budhu A., Forgues M., Ye Q.H., Jia H.L., He P., Zanetti K.A., et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10 (2006) 99-111
6. Gao Q., Qiu S.J., Fan J., Zhou J., Wang X.Y., Xiao Y.S., et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25 (2007) 2586-2593
7. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5 (2005) 263-274
8. + regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol 45 (2006) 254-262
9. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
10. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117 (2007) 1175-1183
11. Kuang D.M., Wu Y., Chen N., Cheng J., Zhuang S.M., and Zheng L. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 110 (2007) 587-595
12. Kuang D.M., Zhao Q.Y., Xu J., Yun J.P., Wu C., and Zheng L. Tumor-educated tolerogenic dendritic cells induce CD3ε down-regulation and apoptosis of T cells through oxygen-dependent pathways. J Immunol 181 (2008) 3089-3098
13. Gajewski T.F. The expanding universe of regulatory T cell subsets in cancer. Immunity 27 (2007) 185-187
14. Wang H.Y., and Wang R.F. Regulatory T cells and cancer. Curr Opin Immunol 19 (2007) 217-223
15. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
16. Weaver C.T., Hatton R.D., Mangan P.R., and Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25 (2007) 821-852
17. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
18. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8 (2008) 337-348
19. Stockinger B., and Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 19 (2007) 281-286
20. Langowski J.L., Kastelein R.A., and Oft M. Swords into plowshares: IL-23 repurposes tumor immune surveillance. Trends Immunol 28 (2007) 207-212
21. Langowski J.L., Zhang X., Wu L., Mattson J.D., Chen T., Smith K., et al. IL-23 promotes tumour incidence and growth. Nature 442 (2006) 461-465
22. Numasaki M., Fukushi J., Ono M., Narula S.K., Zavodny P.J., Kudo T., et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101 (2003) 2620-2627
23. Tartour E., Fossiez F., Joyeux I., Galinha A., Gey A., Claret E., et al. Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 59 (1999) 3698-3704
24. Kryczek I., Wei S., Zou L., Altuwaijri S., Szeliga W., Kolls J., et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 178 (2007) 6730-6733
25. Chen M.S., Li J.Q., Zheng Y., Guo R.P., Liang H.H., Zhang Y.Q., et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243 (2006) 321-328
26. Shi M., Guo R.P., Lin X.J., Zhang Y.Q., Chen M.S., Zhang C.Q., et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245 (2007) 36-43
27. Sun H.C., Zhang W., Qin L.X., Zhang B.H., Ye Q.H., Wang L., et al. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol 47 (2007) 684-690
28. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pages C., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313 (2006) 1960-1964
29. Moser B., and Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2 (2001) 123-128
30. Benchetrit F., Ciree A., Vives V., Warnier G., Gey A., Sautes-Fridman C., et al. Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 99 (2002) 2114-2121
31. Muranski P., Boni A., Antony P.A., Cassard L., Irvine K.R., Kaiser A., et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112 (2008) 362-373
32. Mantovani A., Romero P., Palucka A.K., and Marincola F.M. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 371 (2008) 771-783
33. Dunn G.P., Koebel C.M., and Schreiber R.D. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6 (2006) 836-848
34. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 204 (2007) 1849-1861
35. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8 (2007) 639-646
36. Bromley S.K., Thomas S.Y., and Luster A.D. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 6 (2005) 895-901
37. Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10 (2004) 942-949
38. + T cell trafficking and development by IFN-γ: mechanism and pathological relevance in psoriasis. J Immunol 181 (2008) 4733-4741
39. + IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA 105 (2008) 15505-15510